215 related articles for article (PubMed ID: 24755306)
1. Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model.
Ho SC; Hsu CC; Pawlak CR; Tikhonova MA; Lai TJ; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2014 Jul; 268():177-84. PubMed ID: 24755306
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia.
Hsu CY; Hung CS; Chang HM; Liao WC; Ho SC; Ho YJ
Neuropharmacology; 2015 Apr; 91():43-56. PubMed ID: 25499022
[TBL] [Abstract][Full Text] [Related]
3. Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model.
Hsieh MH; Gu SL; Ho SC; Pawlak CR; Lin CL; Ho YJ; Lai TJ; Wu FY
Behav Brain Res; 2012 Apr; 229(1):41-7. PubMed ID: 22227506
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson's disease dementia.
Hsieh MH; Meng WY; Liao WC; Weng JC; Li HH; Su HL; Lin CL; Hung CS; Ho YJ
Brain Res Bull; 2017 Jun; 132():129-138. PubMed ID: 28576659
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of ceftriaxone and erythropoietin on neuronal and behavioral deficits in an MPTP-induced animal model of Parkinson's disease dementia.
Huang CK; Chang YT; Amstislavskaya TG; Tikhonova MA; Lin CL; Hung CS; Lai TJ; Ho YJ
Behav Brain Res; 2015 Nov; 294():198-207. PubMed ID: 26296668
[TBL] [Abstract][Full Text] [Related]
6. Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model.
Hsieh MH; Ho SC; Yeh KY; Pawlak CR; Chang HM; Ho YJ; Lai TJ; Wu FY
Pharmacol Biochem Behav; 2012 Jul; 102(1):64-71. PubMed ID: 22487770
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease.
Castro AA; Wiemes BP; Matheus FC; Lapa FR; Viola GG; Santos AR; Tasca CI; Prediger RD
Brain Res; 2013 Jun; 1513():103-16. PubMed ID: 23548600
[TBL] [Abstract][Full Text] [Related]
8. Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia.
Ho YJ; Ho SC; Pawlak CR; Yeh KY
Behav Brain Res; 2011 Jun; 219(2):280-90. PubMed ID: 21262271
[TBL] [Abstract][Full Text] [Related]
9. Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion.
Ramírez-García G; Palafox-Sánchez V; Limón ID
Neuroscience; 2015 Apr; 290():492-508. PubMed ID: 25644418
[TBL] [Abstract][Full Text] [Related]
10. Measuring attention in a Parkinson's disease rat model using the 5-arm maze test.
Ho SC; Hsu CC; Yu CH; Huang WN; Tikhonova MA; Ho MC; Hung CS; Amstislavskaya TG; Ho YJ
Physiol Behav; 2014 May; 130():176-81. PubMed ID: 24690450
[TBL] [Abstract][Full Text] [Related]
11. MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats.
Wang WF; Wu SL; Liou YM; Wang AL; Pawlak CR; Ho YJ
Behav Neurosci; 2009 Dec; 123(6):1261-70. PubMed ID: 20001109
[TBL] [Abstract][Full Text] [Related]
12. Lesion of the substantia nigra, pars compacta impairs delayed alternation in a Y-maze in rats.
Braga R; Kouzmine I; Canteras NS; Da Cunha C
Exp Neurol; 2005 Mar; 192(1):134-41. PubMed ID: 15698627
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease.
Haga H; Matsuo K; Yabuki Y; Zhang C; Han F; Fukunaga K
Neurochem Int; 2019 Oct; 129():104492. PubMed ID: 31229554
[TBL] [Abstract][Full Text] [Related]
14. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats.
Wang AL; Liou YM; Pawlak CR; Ho YJ
Behav Brain Res; 2010 Mar; 208(1):38-46. PubMed ID: 19900486
[TBL] [Abstract][Full Text] [Related]
15. MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus.
Sy HN; Wu SL; Wang WF; Chen CH; Huang YT; Liou YM; Chiou CS; Pawlak CR; Ho YJ
Pharmacol Biochem Behav; 2010 Apr; 95(2):158-65. PubMed ID: 20064549
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson's disease rat model: An immunohistochemical and MRI study.
Weng JC; Tikhonova MA; Chen JH; Shen MS; Meng WY; Chang YT; Chen KH; Liang KC; Hung CS; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2016 May; 305():126-39. PubMed ID: 26940602
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism.
Bonito-Oliva A; Pignatelli M; Spigolon G; Yoshitake T; Seiler S; Longo F; Piccinin S; Kehr J; Mercuri NB; Nisticò R; Fisone G
Biol Psychiatry; 2014 May; 75(9):701-10. PubMed ID: 23541633
[TBL] [Abstract][Full Text] [Related]
18. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
[TBL] [Abstract][Full Text] [Related]
19. Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.
Santos DB; Colle D; Moreira EL; Hort MA; Godoi M; Le Douaron G; Braga AL; Assreuy J; Michel PP; Prediger RD; Raisman-Vozari R; Farina M
Mol Neurobiol; 2017 Mar; 54(2):1513-1530. PubMed ID: 26852411
[TBL] [Abstract][Full Text] [Related]
20. Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
Castro AA; Ghisoni K; Latini A; Quevedo J; Tasca CI; Prediger RD
Behav Brain Res; 2012 Apr; 229(1):208-15. PubMed ID: 22266923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
